Stay updated with breaking news from Johnc Klock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BioMarin Pharmaceutical (NASDAQ:BMRN – Get Rating) issued an update on its FY 2023 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $1.80-$2.05 for the period, compared to the consensus estimate of $0.95. The company issued revenue guidance of $2.38 billion-$2.50 billion, compared to the consensus revenue estimate of $2.46 […]
BioMarin Pharmaceutical (NASDAQ:BMRN – Get Rating) had its target price raised by Robert W. Baird from $112.00 to $127.00 in a report issued on Thursday morning, The Fly reports. A number of other brokerages have also recently issued reports on BMRN. StockNews.com began coverage on shares of BioMarin Pharmaceutical in a research note on Thursday, […]
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) was the target of a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 6,430,000 shares, a growth of 8.2% from the March 31st total of 5,940,000 shares. Approximately 3.5% of the company’s shares are sold short. Based […]
BioMarin Pharmaceutical (NASDAQ:BMRN – Get Rating) issued an update on its FY 2023 earnings guidance on Thursday morning. The company provided earnings per share guidance of $1.80-$2.05 for the period, compared to the consensus earnings per share estimate of $0.95. The company issued revenue guidance of $2.38 billion-$2.50 billion, compared to the consensus revenue estimate […]
BioMarin Pharmaceutical (NASDAQ:BMRN – Get Rating) issued an update on its FY 2023 earnings guidance on Thursday morning. The company provided earnings per share guidance of $1.80-$2.05 for the period, compared to the consensus earnings per share estimate of $0.95. The company issued revenue guidance of $2.38 billion-$2.50 billion, compared to the consensus revenue estimate […]